Ginsenoside Rd mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1 signaling pathway

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 8, 2015, Pages 14497-14504

  Zeng, Xiaofeng ^a   Li, Juan ^b   Li, Zhen ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b YUNNAN PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Ginsenoside Rd; Myocardial ischemia reperfusion injury; Nrf2 HO 1

Indexed keywords

CREATINE KINASE; GINSENOSIDE RD; HEME OXYGENASE 1; LACTATE DEHYDROGENASE; TRANSCRIPTION FACTOR NRF2; TROPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR CATHETER; DRUG EFFICACY; ENZYME ACTIVITY; HEART FUNCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE PRESSURE; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84943591742     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Lu MJ, Chen YS, Huang HS and Ma MC. Hypox­ic preconditioning protects rat hearts against ischemia-reperfusion injury via the arachido­nate12-lipoxygenase/transient receptor po­tential vanilloid 1 pathway. Basic Res Cardiol 2014; 109: 414.
2. Heusch G. Cardioprotection: chances and chal­lenges of its translation to the clinic. Lancet 2013; 381: 166-175.
3. Heusch G, Musiolik J, Gedik N and Skyschally A. Mitochondrial STAT3 activation and cardio­protection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfu­sion. Circ Res 2011; 109: 1302-1308.
4. Wang Z, Wang Y, Ye J, Lu X, Cheng Y, Xiang L, Chen L, Feng W, Shi H, Yu X, Lin L, Zhang H, Xiao J and Li X. bFGF attenuates endoplasmic reticulum stress and mitochondrial injury on myocardial ischaemia/reperfusion via activa­tion of PI3K/Akt/ERK1/2 pathway. J Cell Mol Med 2015; 19: 595-607.
5. Yang Y, Duan W, Lin Y, Yi W, Liang Z, Yan J, Wang N, Deng C, Zhang S, Li Y, Chen W, Yu S, Yi D and Jin Z. SIRT1 activation by curcumin pre­treatment attenuates mitochondrial oxidative damage induced by myocardial ischemia re­perfusion injury. Free Radic Biol Med 2013; 65: 667-679.
6. Han J, Wang M, Jing X, Shi H, Ren M and Lou H. (-)-Epigallocatechin gallate protects against ce­rebral ischemia-induced oxidative stress via Nrf2/ARE signaling. Neurochem Res 2014; 39: 1292-1299.
7. He M, Pan H, Chang RC, So KF, Brecha NC and Pu M. Activation of the Nrf2/HO-1 antioxidant pathway contributes to the protective effects of Lycium barbarum polysaccharides in the ro­dent retina after ischemia-reperfusion-induced damage. PLoS One 2014; 9: e84800.
8. Li W, Wu M, Tang L, Pan Y, Liu Z, Zeng C, Wang J, Wei T and Liang G. Novel curcumin analo-gue 14p protects against myocardial ische-mia reperfusion injury through Nrf2-activating anti-oxidative activity. Toxicol Appl Pharmacol 2015; 282: 175-183.
9. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M and Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating in­duction of phase 2 enzymes that protect ag-ainst carcinogens and oxidants. Proc Natl Acad Sci U S A 2002; 99: 11908-11913.
10. Itoh K, Tong KI and Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electro­philes. Free Radic Biol Med 2004; 36: 1208-1213.
11. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, Kang MI, Kobayashi A, Yamamoto M, Kensler TW and Talalay P. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci U S A 2004; 101: 2040-2045.
12. Jia L and Zhao Y. Current evaluation of the mil­lennium phytomedicine--ginseng (I): etymolo­gy, pharmacognosy, phytochemistry, market and regulations. Curr Med Chem 2009; 16: 2475-2484.
13. Liu XY, Zhou XY, Hou JC, Zhu H, Wang Z, Liu JX and Zheng YQ. Ginsenoside Rd promotes neu­rogenesis in rat brain after transient focal ce­rebral ischemia via activation of PI3K/Akt pathway. Acta Pharmacol Sin 2015; 36: 421-428.
14. Ye R, Li N, Han J, Kong X, Cao R, Rao Z and Zhao G. Neuroprotective effects of ginsenosi-de Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neurosci Res 2009; 64: 306-310.
15. Ye R, Han J, Kong X, Zhao L, Cao R, Rao Z and Zhao G. Protective effects of ginsenoside Rd on PC12 cells against hydrogen peroxide. Biol Pharm Bull 2008; 31: 1923-1927.
16. Zhang YX, Wang L, Xiao EL, Li SJ, Chen JJ, Gao B, Min GN, Wang ZP and Wu YJ. Ginsenoside-Rd exhibits anti-inflammatory activities through elevation of antioxidant enzyme activities and inhibition of JNK and ERK activation in vivo. Int Immunopharmacol 2013; 17: 1094-1100.
17. Guan YY, Zhou JG, Zhang Z, Wang GL, Cai BX, Hong L, Qiu QY and He H. Ginsenoside-Rd from panax notoginseng blocks Ca2+ influx through receptor- and store-operated Ca2+ channels in vascular smooth muscle cells. Eur J Pharmacol 2006; 548: 129-136.
18. Li XY, Liang J, Tang YB, Zhou JG and Guan YY. Ginsenoside Rd prevents glutamate-induced apoptosis in rat cortical neurons. Clin Exp Pharmacol Physiol 2010; 37: 199-204.
19. Zhang X, Shi M, Ye R, Wang W, Liu X, Zhang G, Han J, Zhang Y, Wang B, Zhao J, Hui J, Xiong L and Zhao G. Ginsenoside Rd attenuates tau protein phosphorylation via the PI3K/AKT/GSK-3beta pathway after transient forebrain ischemia. Neurochem Res 2014; 39: 1363-1373.
20. Sun D, Wang B, Shi M, Zhang YX, Zhou LF, Liu ZR, Wu ZL, Jiang W, Han JL, Xiong LZ and Zhao G. Pharmacokinetic, tissue distribution and ex­cretion of ginsenoside-Rd in rodents. Phyto­medicine 2012; 19: 369-373.
21. Xie CL, Li JH, Wang WW, Zheng GQ and Wang LX. Neuroprotective effect of ginsenoside-Rg1 on cerebral ischemia/reperfusion injury in rats by downregulating protease-activated recep­tor-1 expression. Life Sci 2015; 121: 145-151.
22. Zhu D, Liu M, Yang Y, Ma L, Jiang Y, Zhou L, Huang Q, Pi R and Chen X. Ginsenoside Rd ameliorates experimental autoimmune ence-phalomyelitis in C57BL/6 mice. J Neurosci Res 2014; 92: 1217-1226.
23. Wu LL, Jia BH, Sun J, Chen JX, Liu ZY and Liu Y. Protective effects of ginsenoside Rb1 on septic rats and its mechanism. Biomed Environ Sci 2014; 27: 300-303.
24. Ma L, Liu H, Xie Z, Yang S, Xu W, Hou J and Yu B. Ginsenoside Rb3 protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of JNK-mediated NF-kappaB path­way: a mouse cardiomyocyte model. PLoS One 2014; 9: e103628.
25. Shi Y, Han B, Yu X, Qu S and Sui D. Ginsenoside Rb3 ameliorates myocardial ischemia-reperfu­sion injury in rats. Pharm Biol 2011; 49: 900-906.
26. Peng L, Sun S, Xie LH, Wicks SM and Xie JT. Ginsenoside Re: pharmacological effects on cardiovascular system. Cardiovasc Ther 2012; 30: e183-188.
27. Xia R, Zhao B, Wu Y, Hou JB, Zhang L, Xu JJ and Xia ZY. Ginsenoside Rb1 preconditioning en­hances eNOS expression and attenuates myo­cardial ischemia/reperfusion injury in diabe-tic rats. J Biomed Biotechnol 2011; 2011: 767930.
28. Wang Z, Li M, Wu WK, Tan HM and Geng DF. Ginsenoside Rb1 preconditioning protects ag-ainst myocardial infarction after regional isch­emia and reperfusion by activation of phos­phatidylinositol-3-kinase signal transduction. Cardiovasc Drugs Ther 2008; 22: 443-452.
29. Shah ZA, Li RC, Thimmulappa RK, Kensler TW, Yamamoto M, Biswal S and Dore S. Role of re­active oxygen species in modulation of Nrf2 following ischemic reperfusion injury. Neuro­science 2007; 147: 53-59.
30. Siow RC, Sato H and Mann GE. Heme oxygen­ase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bi-lirubin and carbon monoxide? Cardiovasc Res 1999; 41: 385-394.
31. Wu J, Li Q, Wang X, Yu S, Li L, Wu X, Chen Y, Zhao J and Zhao Y. Neuroprotection by curcum­in in ischemic brain injury involves the Akt/Nrf2 pathway. PLoS One 2013; 8: e59843.
32. Niture SK and Jaiswal AK. INrf2 (Keap1) tar­gets Bcl-2 degradation and controls cellular apoptosis. Cell Death Differ 2011; 18: 439-451.